Search Results 1501-1510 of 19451 for Hemoglobin

1. Bemarituzumab plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab Alone - Mayo Clinic

   - Hemoglobin ≥ 9 g/dL without red blood cell (RBC) transfusion within 7 days prior to the first dose of study treatment - Aspartate aminotransaminase (AST) ...

2. Neurosurgery - Clinical trials

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

3. Tocilizumab In The Treatment Of Refractory Polymyositis And Dermatomyositis - Mayo Clinic

   Participation eligibility · Serum creatinine > 1.6 mg/dL in female patients and > 1.9 mg/dL in male patients. · Platelet count < (100,000/mm3); hemoglobin < 8.5 g ...

4. Rilonacept in Subjects with Cardiac Sarcoidosis - Mayo Clinic

   Hemoglobin level \< 8.0 g/dL 2. WBC count \< 3.0 × 103/µL 3. Neutrophil count \<1.5 × 103/µL 4. Platelet count \< 100 × 103/µL 5. Total bilirubin level ...

5. Testing The Addition Of High Dose, Targeted Radiation To The Usual Treatment For Locally-Advanced Inoperable Non-small Cell Lung Cancer - Mayo Clinic

   - Hematologic function (e.g. platelets, leukocytes, hemoglobin) amenable, at the discretion of the treating physician, to allow for treatment with ...

6. IFX_HU2.0 As An Adjunctive Therapy To Pembrolixumab In Checkpoint Inhibitor Naive Subjects With Advanced Or Metastatic Merkel Cell Carcinoma - Mayo Clinic

   Hemoglobin (Hb) ≥ 9.0 g/dL; White Blood Cell Count (WBC) > LLN - 3,000 cells/mcL; Platelet count (PLT) > LLN - 75,000 /mcL. Blood Coagulation Parameters: PT ...

7. Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL, independent of transfusion and/or growth factors within 90 days prior to Step 1 registration. Platelet count ≥ 100,000 x 10^9/uL ...

8. Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL; Prothrombin time (PT)/international normalized ratio (INR) < 1.25 x ULN (Cohort II [MTD] only); Cholesterol < Common Terminology ...

9. A Study Comparing Gemcitabine with or without AZD 1775 in Treating Patients with Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   Hemoglobin ≥ 90 g/L. Blood transfusions are allowed at any time during the screening, treatment or follow-up period, according to the center recommendations.

10. A Study to Evaluate Estetrol to Treat Moderate-to-Severe Vasomotor Symptoms in Postmenopausal Women - Mayo Clinic

    ... hemoglobin above 7%; 9. Dyslipoproteinaemia (LDL >190 mg/dL and triglycerides >300 mg/dL); 10. Smoking: 1. Efficacy Study part: subjects smoking >5 ...